Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,004 public trials 571 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

NCT03934684

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Yashoda Hospital Hyderabad, Andhra Pradesh, India
  • Apollo Hospital Hyderabad, Andhra Pradesh, India
  • M S Ramaiah Memorial Hospital Bangalore, Karnataka, India
  • K L E S Dr Prabhakar Kore Hospital and Medical Research Centre Belagavi, Karnataka, India
View all 17 locations
View Trial Details
Completed

Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma

NCT05064358

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • GSK Investigational Site West Palm Beach, Florida, United States
  • GSK Investigational Site Kansas City, Missouri, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Chattanooga, Tennessee, United States
View all 77 locations
View Trial Details
Completed

First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM)

NCT04083534

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Regeneron Study Site Indianapolis, Indiana, United States
  • Regeneron Study Site Ann Arbor, Michigan, United States
  • Regeneron Study Site Rochester, Minnesota, United States
  • Regeneron Study Site New York, United States
View Trial Details
Completed

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

NCT01231412

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +58 more
Locations
  • University of Colorado Denver, Colorado, United States
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
View Trial Details
Completed

Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT01816971

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Dana Farber Boston, Massachusetts, United States
  • Washington University in St Louis St Louis, Missouri, United States
  • Sarah Cannon Cancer Center Nashville, Tennessee, United States
View Trial Details

Related conditions